Ebenezer K. Quainoo (Baltimore Healthcare, PC)

Baltimore Healthcare, PC has served the Baltimore, MD community since 2004 under the leadership of Dr. Ebenezer K. Quainoo, a board-certified internist who integrates primary care with specialized services in weight management and addiction medicine. The practice operates from its Baltimore location with both in-person consultations and telehealth options, allowing patients across Maryland to access Dr. Quainoo's clinical expertise. With over two decades of experience in internal medicine, the clinic addresses chronic disease management, preventive care, and metabolic health concerns through evidence-based protocols that combine traditional internal medicine with contemporary therapeutic approaches.

For patients struggling with weight management, Baltimore Healthcare, PC offers semaglutide therapy as part of a medically supervised weight loss program. Semaglutide, a GLP-1 receptor agonist peptide, works by regulating appetite and glucose metabolism, and Dr. Quainoo prescribes this medication within the context of comprehensive metabolic evaluation and ongoing monitoring. The weight loss program includes baseline laboratory assessment, body composition analysis, nutritional counseling, and regular follow-up appointments to adjust dosing and track progress. Patients receive individualized treatment plans that account for comorbid conditions such as type 2 diabetes, hypertension, and cardiovascular risk factors commonly managed within the internal medicine scope of practice.

Dr. Quainoo's training in addiction medicine allows Baltimore Healthcare, PC to provide integrated care for patients whose weight concerns intersect with substance use disorders or behavioral health challenges. This dual focus enables the practice to address the complex relationship between metabolic dysfunction, mental health, and addictive behaviors within a single clinical setting. The internal medicine foundation ensures that all interventions, including peptide therapy, are implemented with attention to drug interactions, contraindications, and the patient's complete medical history. Dr. Quainoo conducts thorough medication reconciliation and coordinates care with specialists when patients require multidisciplinary management.

Patients at Baltimore Healthcare, PC can expect a clinical environment where administrative processes are streamlined to minimize barriers to care, with front desk staff trained to handle insurance verification and prior authorization requirements for medications like semaglutide. The nursing team supports patient education, administers injections when needed, and provides coaching on self-administration techniques for at-home use. Appointment scheduling accommodates both routine primary care visits and focused weight management consultations, with telehealth visits available for follow-up assessments, medication adjustments, and ongoing support between in-person evaluations. This flexibility proves particularly valuable for patients managing chronic conditions that require frequent provider contact.

Located in Baltimore, Maryland, the practice serves patients throughout the greater Baltimore metropolitan area and extends its reach through telehealth services to individuals across the state who may face transportation challenges or prefer virtual consultations. Dr. Quainoo's approach emphasizes patient education and shared decision-making, ensuring individuals understand the mechanism of action, expected outcomes, and potential side effects of semaglutide therapy before initiating treatment. The practice maintains a 4.8-star rating across 118 Google reviews, reflecting consistent patient feedback regarding clinical competence, accessibility, and the interpersonal skills of the entire care team. Baltimore Healthcare, PC accepts most major insurance plans and works with patients to navigate coverage for both primary care services and specialized treatments including prescription weight loss medications.